Alembic Pharmaceuticals shines on entering into agreement with US based ABP

08 Aug 2012 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 64.00, up by 0.40 points or 0.63% from its previous closing of Rs. 63.60 on the BSE.

The scrip opened at Rs. 64.00 and has touched a high and low of Rs. 65.50 and Rs. 62.75 respectively. So far 91,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 66.60 on 07-Aug-2012 and a 52 week low of Rs. 34.00 on 06-Jan-2012.

Last one week high and low of the scrip stood at Rs. 66.60 and Rs. 60.50 respectively. The current market cap of the company is Rs. 1,206 crore.

The promoters holding in the company stood at 74.13% while Institutions and Non-Institutions held 7.62% and 18.25% respectively.

Alembic Pharmaceuticals has entered into a development and license agreement with Accu Break Pharmaceuticals, Inc, USA (ABP) to develop new brand products that will use ABP’s innovative ACCU break tablet technologies. The first product that ABP will seek Food and Drug Administration marketing approval for is an Accu-Break-formatted version of the popular anticoagulant medication warfarin.

Further, ABP’s patented Accu Break tablets can be split easily by hand into exact smaller doses to provide maximum flexibility, and to make it easier and safer for patients and caregivers to adjust their doses.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×